BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34935057)

  • 1. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
    Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
    Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs.
    Kerslake R; Randeva HS; Jonigk D; Werlein C; Robertus JL; Katopodis P; Jasker P; Spandidos DA; Kyrou I; Karteris E
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35211765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of host factors in SARS-CoV-2 entry.
    Evans JP; Liu SL
    J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
    Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
    J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
    Huang C; Jiang Y; Yan J
    J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
    Gadanec LK; McSweeney KR; Qaradakhi T; Ali B; Zulli A; Apostolopoulos V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues.
    Hu RW; Liu C; Gong JP; Cao ZX
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2409-2414. PubMed ID: 33755980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.
    Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH
    Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
    Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
    Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells.
    Benedetti F; Silvestri G; Mavian C; Weichseldorfer M; Munawwar A; Cash MN; Dulcey M; Vittor AY; Ciccozzi M; Salemi M; Latinovic OS; Zella D
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells.
    Imperio GE; Lye P; Mughis H; Hamada H; Bloise E; Lye SJ; Matthews SG
    Microvasc Res; 2021 Nov; 138():104232. PubMed ID: 34416267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML
    Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.
    Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Karteris E; Kyrou I
    Mol Med Rep; 2020 Nov; 22(5):4221-4226. PubMed ID: 33000221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.